Despite the new obstacles presented by COVID-19, and a temporary halt to face-to-face lobbying, CRN worked to build and maintain a positive legislative, regulatory, and commercial environment for nutritional products to foster consumer confidence and industry growth.
In 2020, CRN and our members shaped policy by:
- Conducting our first-ever virtual lobbying event, the Supplement Advocacy Send-In, in lieu of our annual Day on the Hill, with more than 100 letters sent to Congress
- Advocating for mandatory product listing for dietary supplements
- Urging FDA and Congress to create a legal pathway to market CBD in dietary supplements
- Calling for state CBD legislation to mirror federal regulations for dietary supplements to avoid a patchwork of laws that would impede simultaneous compliance with anticipated federal regulations
- Opposing age-restriction legislation introduced in several states
- Opposing private right-of-action proposals in the states
- Encouraging tax code revisions to allow certain dietary supplements to be purchased with pre-tax dollars, via Health Savings Accounts (HSAs)/Flexible Spending Accounts (FSAs)
- Submitting amicus briefs to the courts to shape judicial decisions involving supplements
- Proposing a master file framework to FDA to support intellectual property protection in New Dietary Ingredient (NDI) notifications
- Advocating for the appropriate role of supplementation in the Dietary Guidelines for Americans
READ ON — Supporting 'the science behind the supplements'
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16